- Facing pharmacy trends for the remainder of the year
- Americans more likely than others to prefer generics, study finds
- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
- Generic drug prices spike, but PBMs' reimbursement rates don't keep up, NCPA study finds
- State of the market: Are generic drugs approaching their peak?
PARSIPPANY, N.J. — Generic drug maker Watson Pharmaceuticals has launched its version of a contraceptive made by Bayer HealthCare Pharmaceuticals, Watson said.
The company announced the launch of Vestura (drospirenone and ethinyl estradiol), a generic version of Bayer's Yaz.
Yaz and its generic versions had sales of about $510 million during the 12-month period ended in November, according to IMS.